Investview, Inc. 8-K

What Happened
Investview, Inc. filed an 8‑K disclosing that on January 28, 2026 the company appointed Robert Verdun to its Board of Directors. The appointment was announced in a press release dated February 3, 2026 and was made pursuant to designation rights held by David B. Rothrock (DBR Capital) under a Voting Agreement dated April 27, 2020 (amended November 9, 2020).

Key Details

• Director appointment: Robert Verdun (age 60), effective January 28, 2026; appointment announced Feb 3, 2026.
• Option grant: 25,000,000 options to purchase common stock at $0.05 per share under the 2022 Incentive Plan. Vesting: 5,000,000 shares vest on each of Feb 5 in 2027, 2028, 2029, 2030 and 2031, only if he remains a director or covered person on each vesting date.
• Background highlights: Verdun is CEO of Scaling Up Network LLC, Senior Partner at Solyco Capital, a director (since Dec 2020) and audit committee chair at United Wholesale Mortgage, and a director at Medwatch Technologies (since June 2025).
• Governance/conditions: Verdun’s appointment is subject to the company’s charter, Nevada law, certain cause-related events in his appointment letter, Rothrock’s right to remove/replace him, and future election by stockholders at the next annual meeting.
• Compensation: He will receive customary non‑employee director pay and participate in director plans described in the company’s 2024 Form 10‑K. The press release is filed as Exhibit 99.1 to the 8‑K.

Why It Matters
This filing informs investors that Investview added a director with private equity, executive coaching, and public company board experience, and that the appointment was made under existing investor designation rights (DBR Capital). The 25 million‑option grant at $0.05 is a concrete compensation item that could lead to future share issuance if exercised and vested; vesting is tied to continued service as a director. The appointment remains subject to corporate governance conditions and future stockholder election.